GILL; Saar

Patent Applications and Registrations

Patent applications and USPTO patent grants for GILL; Saar.The latest application filed is for "methods and composition for gene delivery using an engineered viral particle".

Company Profile

20.21.51

GILL; Saar - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Composition For Gene Delivery Using An Engineered Viral Particle App 20220296643 - GILL; Saar	2022-09-22
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220281947 - GILL; Saar ; et al.	2022-09-08
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,407,805 - Gill , et al. August 9, 2	2022-08-09
Compositions And Methods For Crispr/cas9 Knock-out Of Cd33 In Human Hematopoietic Stem / Progenitor Cells For Allogenic Transplantation In Patients With Relapsed - Refractory Acute Myeloid Leukemia App 20220202900 - GILL; Saar ; et al.	2022-06-30
Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (car)- Expressing Cell App 20220195010 - Bitter; Hans ; et al.	2022-06-23
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,359,002 - Gill , et al. June 14, 2	2022-06-14
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,332,511 - Gill , et al. May 17, 2	2022-05-17
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,325,963 - Gill , et al. May 10, 2	2022-05-10
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,319,358 - Gill , et al. May 3, 2	2022-05-03
Activation of Antigen Presenting Cells and Methods for Using the Same App 20220119476 - Gill; Saar ; et al.	2022-04-21
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,306,134 - Gill , et al. April 19, 2	2022-04-19
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,306,133 - Gill , et al. April 19, 2	2022-04-19
Compositions And Methods Of Phospholipase A2 Receptor Chimeric Autoantibody Receptor T Cells App 20220098271 - Gill; Saar ; et al.	2022-03-31
Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias App 20220073639 - RUELLA; Marco ; et al.	2022-03-10
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220041688 - GILL; Saar ; et al.	2022-02-10
Mobilized Peripheral Blood As A Source Of Modified Immune Cells App 20220041984 - GILL; Saar	2022-02-10
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220033467 - GILL; Saar ; et al.	2022-02-03
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220033465 - GILL; Saar ; et al.	2022-02-03
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220033468 - GILL; Saar ; et al.	2022-02-03
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220033466 - GILL; Saar ; et al.	2022-02-03
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220002377 - GILL; Saar ; et al.	2022-01-06
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220002376 - GILL; Saar ; et al.	2022-01-06
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20220002375 - GILL; Saar ; et al.	2022-01-06
Methods and composition for gene delivery using an engineered viral particle Grant 11,191,784 - Gill December 7, 2	2021-12-07
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell Grant 11,149,076 - Bitter , et al. October 19, 2	2021-10-19
Methods And Composition For Gene Delivery Using An Engineered Viral Particle App 20210283179 - GILL; Saar	2021-09-16
Combination Therapy With Chimeric Antigen Receptor (car) Therapies App 20210213063 - Isaacs; Randi ; et al.	2021-07-15
Anti-car Compositions And Methods App 20210179709 - Gill; Saar ; et al.	2021-06-17
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof Grant 11,034,749 - Gill , et al. June 15, 2	2021-06-15
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain Grant 11,026,976 - Brannetti , et al. June 8, 2	2021-06-08
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells Grant 11,028,177 - Brogdon , et al. June 8, 2	2021-06-08
Compositions And Methods Of Phospholipase A2 Receptor Chimeric Autoantibody Receptor T Cells App 20210095001 - Gill; Saar ; et al.	2021-04-01
Modified Monocytes/macrophages/dendritic Cells Expressing Chimeric Antigen Receptors And Uses In Diseases And Disorders Associated With Protein Aggregates App 20210046110 - Gill; Saar ; et al.	2021-02-18
Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor App 20210002377 - Brogdon; Jennifer ; et al.	2021-01-07
Methods And Compositions For Gene Editing In Hematopoietic Stem Cells App 20200281975 - GILL; Saar ; et al.	2020-09-10
Modified Monocytes/macrophage Expressing Chimeric Antigen Receptors And Uses Thereof App 20200247870 - Kind Code	2020-08-06
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor App 20200215171 - Brogdon; Jennifer ; et al.	2020-07-09
Treatment of cancer using a CD123 chimeric antigen receptor Grant 10,703,819 - Brogdon , et al.	2020-07-07
Treatment of cancer using a CLL-1 chimeric antigen receptor Grant 10,568,947 - Brogdon , et al. Feb	2020-02-25
Methods and compositions for gene editing in hematopoietic stem cells Grant 10,548,922 - Gill , et al. Fe	2020-02-04
Treatment Of Cancer Using Anti-cd19 Chimeric Antigen Receptor App 20190388471 - June; Carl H. ; et al.	2019-12-26
Compositions and Methods for Regulating CAR T Cells App 20190367610 - June; Carl H. ; et al.	2019-12-05
Treatment And Prevention Of Cytokine Release Syndrome Using A Chimeric Antigen Receptor In Combination With A Kinase Inhibitor App 20190336504 - Gill; Saar ; et al.	2019-11-07
Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (car)- Expressing Cell App 20190292238 - Bitter; Hans ; et al.	2019-09-26
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor Grant 10,357,514 - June , et al. July 23, 2	2019-07-23
Treatment Of Cancer Using A Chimeric Antigen Receptor In Combination With An Inhibitor Of A Pro-m2 Macrophage Molecule App 20190161542 - Gill; Saar ; et al.	2019-05-30
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell Grant 10,253,086 - Bitter , et al.	2019-04-09
Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor App 20180312595 - Brogdon; Jennifer ; et al.	2018-11-01
Biomarkers Predictive Of Cytokine Release Syndrome App 20180252727 - Garfall; Alfred ; et al.	2018-09-06
Methods And Compositions For Gene Editing In Hematopoietic Stem Cells App 20180250339 - GILL; Saar ; et al.	2018-09-06
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof App 20180244748 - GILL; Saar ; et al.	2018-08-30
Combination Of Chimeric Antigen Receptor Therapy And Amino Pyrimidine Derivatives App 20180140602 - Angst; Daniela ; et al.	2018-05-24
Treatment of cancer using a CD123 chimeric antigen receptor Grant 9,815,901 - Brogdon , et al. November 14, 2	2017-11-14
Effective Targeting Of Primary Human Leukemia Using Anti-cd123 Chimeric Antigen Receptor Engineered T Cells App 20170183415 - Brogdon; Jennifer ; et al.	2017-06-29
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells Grant 9,573,988 - Brogdon , et al. February 21, 2	2017-02-21
Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (car)- Expressing Cell App 20160362472 - Bitter; Hans ; et al.	2016-12-15
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor App 20160096892 - Brogdon; Jennifer ; et al.	2016-04-07
Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor App 20160068601 - Brogdon; Jennifer ; et al.	2016-03-10
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor App 20160051651 - Brogdon; Jennifer ; et al.	2016-02-25
Treatment Of Cancer Using Anti-cd19 Chimeric Antigen Receptor App 20150283178 - June; Carl H. ; et al.	2015-10-08
Effective Targeting Of Primary Human Leukemia Using Anti-cd123 Chimeric Antigen Receptor Engineered T Cells App 20140322212 - Brogdon; Jennifer ; et al.	2014-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.